Actively Recruiting
Prospective Validation of Adaptive Radiotherapy (ART) in Patients With Head and Neck Tumors
Led by University Hospital, Essen · Updated on 2024-09-27
50
Participants Needed
1
Research Sites
213 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Adaptive radiotherapy (ART) includes image-guided radiotherapy (IGRT) and also offers further possibilities for plan adaptation. A particularly high benefit can be expected for patients in whom the clinical target volume (CTV) can show a significant change in shape from fraction to fraction due to anatomical deviations. The shape and position constancy of the CTV during the course of the series is examined in this trial. Dosimetric disadvantages of this type have not been reported so far. The aim of this study is to identify patients who benefit from ART at an early stage and to select them for this method, and then to continue to offer ART to this patient group. If a relevant reduction in the minimum planning target volume (PTV) margins with ART compared to IGRT is demonstrated in this study, patients could be treated with ART.
CONDITIONS
Official Title
Prospective Validation of Adaptive Radiotherapy (ART) in Patients With Head and Neck Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- ECOG performance status 0-1
- Histopathological confirmation of tumor
- Willingness and ability to comply with study requirements
- Presence of tumor in the head and neck region
- Medical indication for radiotherapy
You will not qualify if you...
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department for Radiotherapy, University Hospital Essen, National Center for Tumor Diseases (NCT) West
Essen, Germany / NRW, Germany, 45147
Actively Recruiting
Research Team
M
Maja PD Dr. med. Guberina, PD Dr. med. (MD), specialist
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here